Micell Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Micell Technologies's estimated annual revenue is currently $1.5M per year.
- Micell Technologies's estimated revenue per employee is $125,500
- Micell Technologies's total funding is $90.1M.
Employee Data
- Micell Technologies has 12 Employees.
- Micell Technologies grew their employee count by 0% last year.
Micell Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO/Chairman | Reveal Email/Phone |
Micell Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $15.1M | 60 | 7% | N/A | N/A |
#3 | $6M | 24 | 0% | N/A | N/A |
#4 | $24.8M | 99 | -12% | N/A | N/A |
#5 | $19.3M | 77 | 8% | N/A | N/A |
#6 | $28.1M | 112 | 20% | N/A | N/A |
#7 | $3.8M | 15 | -46% | N/A | N/A |
#8 | $19.3M | 77 | 4% | N/A | N/A |
#9 | $45.4M | 181 | 4% | N/A | N/A |
#10 | $6.8M | 27 | N/A | N/A | N/A |
What Is Micell Technologies?
Welcome to Micell Technologies, Inc., a privately-held, early-stage biomedical company dedicated to advancing combination product therapies in the cardiovascular, orthopedic, and drug-delivery areas. Our Supercritical Fluid Technology consists of patented processes and methods for surface modifications of medical devices with specific focus on improvements to current polymer based drug-eluting technologies. Included in our technology platform are exclusively licensed patents from Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.
keywords:N/A
$90.1M
Total Funding
12
Number of Employees
$1.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Micell Technologies News
Raleigh, NC.-based Micell Technologies, a development-stage biomedical company dedicated to developing innovative interventional cardiology systems, announced today that St. Jude Medical, Inc. has made a $15m equity investment in the company. Commenting on the deal, Arthur J. Benvenuto, chairma ...
For Micell Technologies, a Raleigh, N.C., materials company that recently reinvented itself as a developer of drug-releasing stents, perhaps the third time will be the charm. Founded in 1995, Micell specializes in the use of supercritical fluids, which are highly compressed gases that exhibit b ...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $1M | 12 | 0% | N/A |
#3 | $1.6M | 12 | 0% | N/A |
#4 | $1M | 12 | N/A | N/A |
#5 | $2.4M | 12 | 0% | N/A |